Perspectives On The Science

Overview

In “Perspectives on the Science”, we provide commentary on a publication reviewed in our multi-institutional SoCO Journal Club. The comments in this article represent the views of the authors of this Perspectives on the Science piece. It does not represent views of any other members of SoCO or the affiliated institutions.

Volume 3 Issue 1

Volume 2 Issue 1

Volume 1 Issue 2

Volume 1 Issue 1

Immunotherapy and Cardiovascular Health - A Cause for Concern?

2023
In this Perspectives on the Science piece we reflect on the impact of ‘Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque’ by Drobni et al.
May 1, 2023
Miller, David M., Ferris, Laura K., Gupta, Sameer, Brownell, Isaac, Shalhout, Sophia Z.

Perioperative Immunotherapy for High-Risk Resectable Melanoma - A New Standard?

2023
Melanoma
Neoadjuvant
Adjvuant
In this Perspectives on the Science piece we reflect on the impact of the recently published SWOG S1801 trial.
Apr 15, 2023
Vilasi, Serena, Miller, David M., Kaufman, Howard L., Emerick, Kevin S., Shalhout, Sophia Z., Kim, Emily Y., Patel, Vishal A., Garmen, Khalid, Gupta, Sameer, Brownell, Isaac

Skin Cancer Chemoprevention for Transplant Recipients - The Search Continues

2023
CSCC
In this Perspectives on the Science piece, we reflect on the impact of the recently published ONTRANS trial.
Mar 22, 2023
Kaufman, Howard L., Patel, Vishal A., Shalhout, Sophia Z., Gupta, Sameer, Cohen, Sonia, Brownell, Isaac, Miller, David M.

Lacking Overall IMspiration for Triplet Therapy in Melanoma? A Review of the Interim Analysis of IMspire150.

2023
Melanoma
In this Perspectives on the Science piece, we reflect on the impact of the recently published article by Ascierto et al. in Lancet Oncology that provides interim results from IMspire150.
Feb 4, 2023
Miller, David M., Emerick, Kevin S., Patel, Vishal A., Cohen, Sonia, Brownell, Isaac, Lawrence, Donald P.

Tumor-Infiltrating Lymphocyte Therapy for Advanced Melanoma: Ready for Prime Time?

2023
Melanoma
In this Perspectives on the Science piece, we reflect on the impact of the recently published article “Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma”.
Jan 9, 2023
Kim, Emily Y., Shalhout, Sophia Z., Kaufman, Howard L., Emerick, Kevin S., Patel, Vishal A., Garmen, Khalid, Brownell, Isaac, Miller, David M.

Neoadjuvant Nivo/Rela for Resectable Melanoma

2022
Melanoma
Neoadjuvant
Nivo/Rela
In this Perspectives on the Science piece we reflect on the impact of the recently published article Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Dec 5, 2022
Miller, David M., Kaufman, Howard L., Emerick, Kevin S., Cohen, Justine V., Kim, Emily Y., Shalhout, Sophia Z.

Ipi/Nivo for Advanced MCC

2022
Merkel Cell Carcinoma
Ipi/Nivo
In this Perspectives on the Science piece we reflect on the impact of the recently published article “Combined Nivolumab and Ipilimumab with or without Stereotactic Body Radiation Therapy for Advanced Merkel cell carcinoma - A Randomised, Open Label, Phase 2 Trial”.
Nov 21, 2022
Shalhout, Sophia Z., Cohen, Justine V., Garmen, Khalid, Kim, Emily Y., Cohen, Sonia, Miller, David M.

Neoadjuvant ICI for Resectable CSCC

2022
Squamous Cell Carcinoma
Neoadjuvant
In this Perspectives on the Science piece we reflect on the impact of the recently published article “Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma”.
Nov 8, 2022
Miller, David M., Patel, Vishal A., Cohen, Justine V., Garmen, Khalid, Shalhout, Sophia Z.
No matching items